Overall, these single-cell transcriptome and TCR clonotype expansion characterization results suggested the analyzed CD8+ T cells were indeed specific to MAGE-A3-Mp4 epitope, and their TCR peptide sequences can be potentially utilized for NSCLC TCR-T therapy. The gene discussed is MAGEA3; the disease is non-small cell lung carcinoma.